Hims & Hers Health (HIMS) Fundamental Analysis: Revenue, Earnings & Valuation

7.92 / 10

Outperform

Fundamental rating is Outperform with a 7.92/10 score. Strong points include high net cash flow growth per share (Q 0.029), total profit surge (Q 0.033), and robust EPS growth scores. Revenue‑MV and cash metrics lag, but inventory turnover remains efficient.

Analysis Checks(7/10)

Revenue-MV

Value-0.21

Score3/3

Weight19.05%

1M Return6.67%

Net cash flow from operating activities per share (YoY growth rate %)

Value16.11

Score3/3

Weight13.47%

1M Return5.07%

Inventory turnover ratio

Value8.50

Score2/3

Weight4.44%

1M Return1.88%

Net income-Revenue

Value-1.31

Score1/3

Weight1.50%

1M Return0.69%

Basic earnings per share (YoY growth rate %)

Value-1.72

Score3/3

Weight17.17%

1M Return6.64%

Total profit (YoY growth rate %)

Value72.81

Score3/3

Weight15.15%

1M Return5.90%

Net cash flow from operating activities (YoY growth rate %)

Value19.48

Score3/3

Weight14.82%

1M Return5.49%

Cash-UP

Value-1.05

Score1/3

Weight1.79%

1M Return0.84%

Diluted earnings per share (YoY growth rate %)

Value-3.77

Score3/3

Weight17.64%

1M Return6.86%

Cash-MV

Value-1.06

Score0/3

Weight-5.03%

1M Return-2.55%

Is HIMS undervalued or overvalued?

HIMS scores 7.92/10 on fundamentals and holds a Discounted valuation at present. Backed by its 25.23% ROE, 5.47% net margin, 37.89 P/E ratio, 8.99 P/B ratio, and -1.72% earnings growth, these metrics solidify its Outperform investment rating.